“I Am Not Your Experiment” – Thousands Around The World Protest GMO Giant Monsanto
by Tyler Durden
ZeroHedge.com
05/22/2016
A little over a year ago, GMO giant Monsanto was furious at the World Health Organization for linking glypshophate, the chief ingredient in weed killer Roundup, to cancer. As a result Monsanto immediately demanded that WHO retract said report, saying that the report was biased and contradicts regulatory findings that the ingredient, glyphosate, is safe when used as labeled.
A working group at WHO said after reviewing scientific literature it was classifying glyphosate as “probably carcinogenic to humans.” Howeber Monsanto was relentless and said that “we question the quality of the assessment,” according to Philip Miller, Monsanto vice president of global regulatory affairs. “The WHO has something to explain.”
In retrospect it may have been Monsanto who had something to explain, which it did, indirectly, when last week another report was released, this time from the U.N.’s Food and Agriculture Organization (FAO), according to which Roundup’s glyphosphate is unlikely to cause cancer in people. Continuing the explanation, diazinon and malathion, two other pesticides reviewed by the committee, which met last week and published its conclusions on Monday, were also found to be unlikely to be carcinogenic.
“In view of the absence of carcinogenic potential in rodents at human-relevant doses and the absence of genotoxicity by the oral route in mammals, and considering the epidemiological evidence from occupational exposures, the meeting concluded that glyphosate is unlikely to pose a carcinogenic risk to humans from exposure through the diet,” the committee said.
As Reuters itself notes, the conclusions appear to contradict the abovementioned finding by the WHO’s Lyon-based International Agency for Research on Cancer (IARC), which in March 2015 said glyphosate is “probably” able to cause cancer in humans and classified it as a ‘Group 2A’ carcinogen. This is when the alarm bells at Monsanto went off and, according to some, the company’s spending on favorable reports shot through the roof. The result was immediate.
The Rest…HERE
